Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Genetics
|
February 15, 2003
Analysis of Ras-induced overproliferation in Drosophila hemocytes
H Asha, Istvan Nagy, Gabor Kovacs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 27, 2019
Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung Cancer
Chia-Chi Hsu, Bin-Chi Liao, Wei-Yu Liao, et al.
JCO Precision Oncology
|
February 1, 2022
Orthogonal Comparison of Four Plasma NGS Tests With Tumor Suggests Technical Factors are a Major Source of Assay Discordance
Daniel Stetson, Ambar Ahmed, Xing Xu, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
September 30, 2023
Primary cilia are critical for tracheoesophageal septation
Lindsey Avery Fitzsimons, Evangelia Tasouri, Marc August Willaredt, et al.
Scientific Reports
|
June 13, 2026
Enrichment of mutated DNA enables ultra-sensitive ctDNA detection in NSCLC using shallow targeted sequencing
Paul Labrousse, Hugh Russell, Daniel Stetson, et al.
Molecular Cancer
|
December 8, 2017
Generation of stable PDX derived cell lines using conditional reprogramming
Alexandra Borodovsky, Travis J McQuiston, Daniel Stetson, et al.
Peerj
|
April 11, 2017
Prioritisation of structural variant calls in cancer genomes
Miika J Ahdesmäki, Brad A Chapman, Pablo Cingolani, et al.
Nature Medicine
|
May 5, 2015
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S Thress, Cloud P Paweletz, Enriqueta Felip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2017
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer
Suresh S Ramalingam, James C-H Yang, Chee Khoon Lee, et al.
The Journal of Molecular Diagnostics : JMD
|
September 25, 2025
Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group
Jonathan Baden, Mark Sausen, Andrew T Anfora, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Genetics
|
February 15, 2003
Analysis of Ras-induced overproliferation in Drosophila hemocytes
H Asha, Istvan Nagy, Gabor Kovacs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 27, 2019
Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung Cancer
Chia-Chi Hsu, Bin-Chi Liao, Wei-Yu Liao, et al.
JCO Precision Oncology
|
February 1, 2022
Orthogonal Comparison of Four Plasma NGS Tests With Tumor Suggests Technical Factors are a Major Source of Assay Discordance
Daniel Stetson, Ambar Ahmed, Xing Xu, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
September 30, 2023
Primary cilia are critical for tracheoesophageal septation
Lindsey Avery Fitzsimons, Evangelia Tasouri, Marc August Willaredt, et al.
Scientific Reports
|
June 13, 2026
Enrichment of mutated DNA enables ultra-sensitive ctDNA detection in NSCLC using shallow targeted sequencing
Paul Labrousse, Hugh Russell, Daniel Stetson, et al.
Molecular Cancer
|
December 8, 2017
Generation of stable PDX derived cell lines using conditional reprogramming
Alexandra Borodovsky, Travis J McQuiston, Daniel Stetson, et al.
Peerj
|
April 11, 2017
Prioritisation of structural variant calls in cancer genomes
Miika J Ahdesmäki, Brad A Chapman, Pablo Cingolani, et al.
Nature Medicine
|
May 5, 2015
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S Thress, Cloud P Paweletz, Enriqueta Felip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2017
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer
Suresh S Ramalingam, James C-H Yang, Chee Khoon Lee, et al.
The Journal of Molecular Diagnostics : JMD
|
September 25, 2025
Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group
Jonathan Baden, Mark Sausen, Andrew T Anfora, et al.
Page
of 3